
Opinion|Videos|October 16, 2026
Bridging Logistics and Closing Takeaways
The faculty define holding and bridging therapy, discuss how they coordinate it with the referring practice, and walk through the timeline.
Advertisement
Episodes in this series

The faculty define holding and bridging therapy, discuss how they coordinate it with the referring practice, and walk through the timeline. They discuss what to do if disease rises or authorization is delayed, and which practical steps need the most lead time for a patient with a long drive and a working caregiver, including early referral. Each panelist then shares one takeaway from the CARTITUDE-2 cohort A data.
Advertisement
Related to this article

Erik Bengtsen, MD, explained how antidepressants may improve quality of life and how he typically works with patients who decline favorable treatment.

Erik Bengtsen, MD, shares a key depression screening question and explains when oncologists can start a low-dose antidepressant.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
3
Proton Therapy Tied to Less Hypothyroidism After Supraclavicular Breast RT
4
ASH Issues New Myelofibrosis Guidelines With 10 Management Recommendations
5

